SCHEMBL20646292

SCHEMBL20646292

COc1cc(O)cc(-c2cccc(C(N)=O)c2)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 3/20 0.59
▸ ERN1 O75460 3/20 0.55
▸ ABL1 P00519 2/20 0.53
▸ ABCB1 P08183 2/20 0.53
▸ BCR P11274 2/20 0.53
▸ CYP1A1 P04798 1/20 0.50
▸ CYP1A2 P05177 1/20 0.50
▸ CYP2E1 P05181 1/20 0.50
▸ CYP3A4 P08684 1/20 0.50
▸ CYP2C8 P10632 1/20 0.50
▸ CYP2D6 P10635 1/20 0.50
▸ CYP2A6 P11509 1/20 0.50
▸ CYP2C9 P11712 1/20 0.50
▸ CYP4B1 P13584 1/20 0.50
▸ CYP2B6 P20813 1/20 0.50
▸ CYP3A5 P20815 1/20 0.50
▸ CYP2A7 P20853 1/20 0.50
▸ CYP3A7 P24462 1/20 0.50
▸ CYP2F1 P24903 1/20 0.50
▸ CYP2C18 P33260 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1690557 0.86 PARP1 (0.80) PARP1ERN1PLAUPLATPLG
SCHEMBL24163686 0.85 PARP1 (0.49) PARP1ERN1PARP10PARP2
SCHEMBL16116617 0.84 PARP1 (0.62) PARP1ERN1ABL1ABCB1BCR
SCHEMBL3720494 0.81 PARP1 (0.67) PARP1ABL1ABCB1BCRCYP1A2
SCHEMBL1147444 0.79 PARP1 (0.77) PARP1ERN1CYP3A4CYP2C9HSD17B2
SCHEMBL3662153 0.78 MKNK1 (0.72) PARP1ERN1CYP1A2CYP3A4CYP2C9
SCHEMBL3659867 0.78 CYP11B1 (0.68) PARP1ERN1CYP1A2CYP3A4PLAU
SCHEMBL17175623 0.77 PARP1 (0.56) PARP1ERN1CHEK2ESR2
SCHEMBL2431097 0.77 PARP1 (0.64) PARP1ERN1CYP3A4CYP2C19
SCHEMBL31422694 0.77 PARP1 (0.64) PARP1ERN1CYP3A4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3988540-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE (FAAH) ENZYME WITH IMPROVED ORAL BIOAVAILABILITY AND THEIR USE AS MEDICAMENTS The Regents of the University of California (US) 2022-04-27 — — EP disclosed
EP-3129354-B1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE (FAAH) ENZYME WITH IMPROVED ORAL BIOAVAILABILITY AND THEIR USE AS MEDICAMENTS UNIV CALIFORNIA (US) 2022-01-05 — — EP disclosed
EP-2744778-B1 META-SUBSTITUTED BIPHENYL PERIPHERALLY RESTRICTED FAAH INHIBITORS UNIV CALIFORNIA (US) 2019-01-16 — — EP disclosed
Send feedback